Co-Authors
This is a "connection" page, showing publications co-authored by Giuseppe Di Tano and Luigi Moschini.
Connection Strength
0.950
-
[Renin-angiotensin system blockers and outcomes during hydroxychloroquine treatment in patients hospitalized for COVID-19 pneumonia]. Rev Esp Cardiol. 2020 Nov; 73(11):964-966.
Score: 0.225
-
Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection. Heart Vessels. 2021 Jan; 36(1):115-120.
Score: 0.223
-
Renin-angiotensin system blockers and outcomes during hydroxychloroquine treatment in patients hospitalized for COVID-19 pneumonia. Rev Esp Cardiol (Engl Ed). 2020 11; 73(11):964-966.
Score: 0.223
-
Late Pulmonary Embolism after COVID-19 Pneumonia despite Adequate Rivaroxaban Treatment. Eur J Case Rep Intern Med. 2020; 7(7):001790.
Score: 0.222
-
Coronary artery disease in patients hospitalised with Coronavirus disease 2019 (COVID-19) infection. Open Heart. 2020 11; 7(2).
Score: 0.057